Recruiting

REB-001Traq™ Device Assessment for Binocular Ocular Function in Normal and Traumatic Brain Injury Subjects

Study Aim

This observational study aims to assess the performance of the Traq™ Device in measuring binocular ocular function in both normal individuals and those with traumatic brain injury, by evaluating device metrics such as bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency.

What is being collected

Device Data

+ device Data

Collected from today forward - Prospective

Device

Who is being recruted

Brain Injuries, Traumatic+8

+ Brain Diseases

+ Brain Injuries

Over 12 Years

+8 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.

Observational

Study Start: July 2026

See protocol details

Summary

Principal SponsorRebiscan, Inc.

Study ContactJustin ShakaMore contacts

Last updated: August 3, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: July 14, 2026

Actual date on which the first participant was enrolled.

An initial, single-center, prospective, non-masked, non-randomized, parallel-arm clinical study designed to collect Traq™ measurement data from normal subjects (normal arm) and subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months (post-TBI arm) to characterize binocular ocular function measurement outcomes across the two study populations.

NCT07742878

Principal SponsorRebiscan, Inc.

Study ContactJustin ShakaMore contacts

Last updated: August 3, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

10 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 12 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Brain Injuries, TraumaticBrain DiseasesBrain InjuriesCentral Nervous System DiseasesCraniocerebral TraumaNervous System DiseasesWounds and InjuriesWounds, NonpenetratingHead Injuries, ClosedTrauma, Nervous SystemBrain Concussion

Criteria

5 inclusion criteria required to participate

Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age)

Age 12 years or older at the time of enrollment

Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm)

Subjects with no history of traumatic brain injury (normal arm)

Show More Criteria

3 exclusion criteria prevent from participating

Concurrent participation in another drug or device clinical investigation

Subject with a history of eye disease which could reduce, or limit reflected polarized light from the retina, such as corneal scarring, cataract, glaucoma, degenerative retinal conditions (e.g., age-related macular degeneration, diabetic retinopathy), or other conditions which may decrease device signal reflectance

Subjects who are pregnant, planning to become pregnant, or are breastfeeding

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Elite Eye Care/Elite Vision Therapy

Waukee, United StatesOpen Elite Eye Care/Elite Vision Therapy in Google Maps

Recruiting

One Study Center